T. Rowe Price Investment Management Portfolio holdings
T. Rowe Price Investment Management, Inc. (TRPIM), a division of T. Rowe Price Group established in August 2022 and headquartered in Baltimore, Maryland, is an active investment manager overseeing hundreds of billions in assets, focusing on equity and fixed-income strategies for institutional clients and sub-advisory mandates. Spun off from the parent company founded in 1937 by Thomas Rowe Price, Jr., TRPIM operates as a distinct entity with around 900 employees, emphasizing a research-driven, long-term approach rooted in fundamental analysis and disciplined risk management. Managing portfolios like large-cap growth and international equity funds, it complements T. Rowe Price’s broader offerings while targeting sophisticated investors such as pension funds and endowments with tailored, high-conviction solutions. Under the leadership of president Rob Sharps, TRPIM upholds the firm’s legacy of integrity and client focus, adapting its founder’s value-oriented philosophy to modern institutional needs.
Top Buys
| 1 |
Veralto
VLTO
|
$1.54B |
| 2 |
Lattice Semiconductor
LSCC
|
$380M |
| 3 |
Canadian Natural Resources
CNQ
|
$333M |
| 4 |
Intuit
INTU
|
$306M |
| 5 |
TechnipFMC
FTI
|
$301M |
Top Sells
| 1 |
Thermo Fisher Scientific
TMO
|
$1.16B |
| 2 |
Texas Instruments
TXN
|
$639M |
| 3 |
Equifax
EFX
|
$567M |
| 4 |
TransUnion
TRU
|
$460M |
| 5 |
PXD
Pioneer Natural Resource Co.
PXD
|
$454M |
Sector Composition
| 1 | Technology | 22.55% |
| 2 | Healthcare | 20.34% |
| 3 | Industrials | 12.93% |
| 4 | Consumer Discretionary | 12.23% |
| 5 | Financials | 12.11% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
601
Costco
COST
$424B
| – | – |
-3,364
| Closed | -$1.9M |
|
602
Credo Technology Group
CRDO
$23.2B
| – | – |
-3,166,963
| Closed | -$48.3M |
|
|
CSR
603
Centerspace
CSR
$1,000M
| – | – |
-140,390
| Closed | -$8.46M |
|
604
Cavco Industries
CVCO
$4.4B
| – | – |
-136,257
| Closed | -$36.2M |
|
605
Darling Ingredients
DAR
$4.99B
| – | – |
-225,557
| Closed | -$11.8M |
|
606
Devon Energy
DVN
$22.6B
| – | – |
-1,589,563
| Closed | -$75.8M |
|
607
Embecta
EMBC
$847M
| – | – |
-502,918
| Closed | -$7.57M |
|
608
Essent Group
ESNT
$6.29B
| – | – |
-413,158
| Closed | -$19.5M |
|
609
Generation Bio
GBIO
$38.9M
| – | – |
-351,146
| Closed | -$13.3M |
|
610
Hubbell
HUBB
$23.2B
| – | – |
-25,780
| Closed | -$8.08M |
|
611
Huntsman Corp
HUN
$1.92B
| – | – |
-375,942
| Closed | -$9.17M |
|
612
Insteel Industries
IIIN
$756M
| – | – |
-223,658
| Closed | -$7.26M |
|
613
Prothena Corp
PRTA
$442M
| – | – |
-853,479
| Closed | -$41.2M |
|
614
Patterson-UTI
PTEN
$2.25B
| – | – |
-6,713,128
| Closed | -$92.9M |
|
615
Replimune Group
REPL
$454M
| – | – |
-727,610
| Closed | -$12.5M |
|
616
REX American Resources
REX
$1.05B
| – | – |
-461,456
| Closed | -$18.8M |
|
617
Roivant Sciences
ROIV
$8.58B
| – | – |
-10,649,397
| Closed | -$124M |
|
618
Repare Therapeutics
RPTX
$72.6M
| – | – |
-1,796,906
| Closed | -$21.7M |
|
619
Saga Communications
SGA
$77.7M
| – | – |
-183,716
| Closed | -$3.94M |
|
620
SiTime
SITM
$5.99B
| – | – |
-274,801
| Closed | -$31.4M |
|
|
621
Texas Instruments
TXN
$170B
| – | – |
-4,018,626
| Closed | -$639M |
|
622
Ventyx Biosciences
VTYX
$185M
| – | – |
-1,032,846
| Closed | -$35.9M |
|
623
Petco
WOOF
$958M
| – | – |
-5,019,607
| Closed | -$20.5M |
|
|
CNR
624
Core Natural Resources, Inc.
CNR
$3.64B
| – | – |
-376,994
| Closed | -$39.6M |
|
|
XIFR
625
XPLR Infrastructure, LP
XIFR
$966M
| – | – |
-1,390,359
| Closed | -$41.3M |
|